ALTRINSIC GLOBAL ADVISORS LLC - Q1 2019 holdings

$2.17 Billion is the total value of ALTRINSIC GLOBAL ADVISORS LLC's 147 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 7.3% .

 Value Shares↓ Weighting
CB SellCHUBB LIMITED$221,427,000
+6.5%
1,580,717
-1.8%
10.22%
+2.5%
WLTW SellWILLIS TOWERS WATSON PUB LTD$182,858,000
-0.3%
1,041,036
-13.8%
8.44%
-4.0%
AON SellAON PLC$159,502,000
+1.1%
934,401
-13.9%
7.36%
-2.7%
VOD BuyVODAFONE GROUP PLC NEWsponsored adr$114,511,000
+2.0%
6,298,764
+8.2%
5.28%
-1.7%
LBTYA SellLIBERTY GLOBAL PLC$102,501,000
+14.7%
4,113,198
-1.8%
4.73%
+10.4%
BIDU SellBAIDU INCspon adr rep a$101,574,000
+3.8%
616,158
-0.1%
4.69%
-0.0%
MDT SellMEDTRONIC PLC$93,150,000
-0.8%
1,022,722
-0.9%
4.30%
-4.4%
KGC SellKINROSS GOLD CORP$82,243,000
+5.5%
23,885,429
-1.3%
3.80%
+1.6%
CHKP SellCHECK POINT SOFTWARE TECH LTord$80,085,000
-11.1%
633,127
-27.9%
3.70%
-14.4%
SLB BuySCHLUMBERGER LTD$77,096,000
+38.3%
1,769,469
+14.5%
3.56%
+33.2%
ABEV SellAMBEV SAsponsored adr$63,697,000
+6.5%
14,813,092
-3.0%
2.94%
+2.5%
CMCSA BuyCOMCAST CORP NEWcl a$56,075,000
+18.4%
1,402,573
+0.8%
2.59%
+14.0%
CTSH BuyCOGNIZANT TECHNOLOGY SOLUTIOcl a$47,896,000
+56.4%
661,097
+37.0%
2.21%
+50.6%
PEP BuyPEPSICO INC$43,692,000
+12.0%
356,523
+1.0%
2.02%
+7.8%
BMY BuyBRISTOL MYERS SQUIBB CO$42,413,000
+50.6%
888,981
+64.1%
1.96%
+45.0%
HIG BuyHARTFORD FINL SVCS GROUP INC$36,039,000
+26.1%
724,843
+12.7%
1.66%
+21.4%
ICE BuyINTERCONTINENTAL EXCHANGE IN$34,932,000
+1.9%
458,787
+0.8%
1.61%
-1.9%
BP SellBP PLCsponsored adr$33,518,000
+14.6%
766,646
-0.6%
1.55%
+10.4%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$31,422,000
+12.2%
280,904
+1.1%
1.45%
+8.0%
TAP BuyMOLSON COORS BREWING COcl b$31,143,000
+7.1%
522,103
+0.9%
1.44%
+3.2%
CHTR BuyCHARTER COMMUNICATIONS INC Ncl a$29,762,000
+71.1%
85,792
+40.6%
1.37%
+64.7%
TV SellGRUPO TELEVISA SAspon adr rep ord$29,692,000
-14.3%
2,684,606
-2.5%
1.37%
-17.5%
EXC BuyEXELON CORP$28,262,000
+12.1%
563,783
+0.8%
1.30%
+7.9%
KR BuyKROGER CO$26,836,000
-9.9%
1,090,877
+0.7%
1.24%
-13.2%
ORCL SellORACLE CORP$26,537,000
-26.1%
494,080
-37.9%
1.22%
-28.9%
PEG BuyPUBLIC SVC ENTERPRISE GRP IN$25,617,000
+15.5%
431,187
+1.2%
1.18%
+11.2%
BIIB BuyBIOGEN INC$25,549,000
-9.3%
108,085
+15.4%
1.18%
-12.7%
EBAY SellEBAY INC$25,414,000
+3.8%
684,264
-21.5%
1.17%0.0%
QCOM BuyQUALCOMM INC$23,731,000
+0.5%
416,124
+0.3%
1.10%
-3.2%
JWN BuyNORDSTROM INC$23,159,000
+13.3%
521,844
+19.0%
1.07%
+9.2%
FDX BuyFEDEX CORP$21,714,000
+14.6%
119,694
+1.9%
1.00%
+10.4%
IONS SellIONIS PHARMACEUTICALS INC$19,290,000
-32.5%
237,645
-55.0%
0.89%
-35.0%
CVS BuyCVS HEALTH CORP$19,229,000
+11.9%
356,541
+36.0%
0.89%
+7.8%
COG BuyCABOT OIL & GAS CORP$17,873,000
+17.4%
684,791
+0.5%
0.82%
+13.0%
EOG BuyEOG RES INC$17,464,000
+10.0%
183,483
+0.8%
0.81%
+5.9%
BKR BuyBAKER HUGHES A GE COcl a$17,405,000
+29.8%
627,897
+0.7%
0.80%
+24.9%
SABR BuySABRE CORP$15,367,000
-0.6%
718,435
+0.6%
0.71%
-4.3%
APA BuyAPACHE CORP$15,082,000
+32.8%
435,119
+0.6%
0.70%
+27.9%
UTX SellUNITED TECHNOLOGIES CORP$12,380,000
+21.0%
96,046
-0.0%
0.57%
+16.5%
CNDT SellCONDUENT INC$10,606,000
-44.0%
766,907
-57.0%
0.49%
-46.1%
AAP SellADVANCE AUTO PARTS INC$10,475,000
-36.3%
61,423
-41.2%
0.48%
-38.7%
ALXN  ALEXION PHARMACEUTICALS INC$8,787,000
+38.9%
65,0000.0%0.41%
+34.0%
SPNE BuySEASPINE HLDGS CORP$8,706,000
-12.4%
577,301
+5.9%
0.40%
-15.7%
TRUP BuyTRUPANION INC$5,286,000
+46.8%
161,450
+14.1%
0.24%
+41.0%
AERI  AERIE PHARMACEUTICALS INC$4,513,000
+31.6%
95,0000.0%0.21%
+26.8%
MMSI SellMERIT MED SYS INC$4,279,000
-3.2%
69,202
-12.6%
0.20%
-7.1%
SGMO BuySANGAMO THERAPEUTICS INC$3,973,000
-8.9%
416,500
+9.6%
0.18%
-12.4%
VYGR  VOYAGER THERAPEUTICS INC$3,635,000
+103.6%
189,9270.0%0.17%
+95.3%
PRQR BuyPROQR THRAPEUTICS N V$2,761,000
-3.5%
199,060
+9.8%
0.13%
-7.3%
BKD  BROOKDALE SR LIVING INC$2,648,000
-1.8%
402,4520.0%0.12%
-5.4%
TS  TENARIS S Asponsored ads$2,500,000
+32.5%
88,4940.0%0.12%
+27.8%
CSU BuyCAPITAL SR LIVING CORP$2,338,000
-34.6%
586,007
+11.4%
0.11%
-36.8%
AACH  AAC HLDGS INC$2,161,000
+31.4%
1,174,3700.0%0.10%
+26.6%
L BuyLOEWS CORP$2,084,000
+15.0%
43,472
+9.2%
0.10%
+10.3%
VIV SellTELEFONICA BRASIL SAsponsored adr$2,023,000
-20.1%
167,587
-21.0%
0.09%
-23.1%
IBN SellICICI BK LTDadr$2,000,000
-95.3%
174,568
-95.8%
0.09%
-95.5%
NUVA SellNUVASIVE INC$1,971,000
-0.6%
34,700
-13.2%
0.09%
-4.2%
NSTG SellNANOSTRING TECHNOLOGIES INC$1,914,000
-59.0%
80,000
-74.6%
0.09%
-60.7%
NVRO SellNEVRO CORP$1,875,000
+37.8%
30,000
-14.3%
0.09%
+33.8%
SHG BuySHINHAN FINANCIAL GROUP CO Lspn adr restrd$1,775,000
+63.0%
47,773
+55.8%
0.08%
+57.7%
NTES BuyNETEASE INCsponsored adr$1,751,000
+102.9%
7,253
+97.8%
0.08%
+97.6%
KURA  KURA ONCOLOGY INC$1,742,000
+18.2%
105,0000.0%0.08%
+12.7%
XENE BuyXENON PHARMACEUTICALS INC$1,626,000
+71.7%
160,000
+6.7%
0.08%
+66.7%
EHC BuyENCOMPASS HEALTH CORP$1,626,000
+3.5%
27,841
+9.3%
0.08%0.0%
CSCO BuyCISCO SYS INC$1,514,000
+36.2%
28,040
+9.3%
0.07%
+32.1%
DVCR  DIVERSICARE HEALTHCARE SVCS$1,451,000
+63.8%
373,9520.0%0.07%
+59.5%
AKCA SellAKCEA THERAPEUTICS INC$1,425,000
-37.2%
50,286
-33.2%
0.07%
-39.4%
CFMS BuyCONFORMIS INC$1,379,000
+795.5%
478,942
+11.7%
0.06%
+814.3%
ARA BuyAMERICAN RENAL ASSOCIATES HO$1,351,000
-2.2%
220,000
+83.3%
0.06%
-6.1%
DRNA NewDICERNA PHARMACEUTICALS INC$1,319,00090,000
+100.0%
0.06%
AGTC BuyAPPLIED GENETIC TECHNOL CORP$1,286,000
+109.1%
306,900
+24.3%
0.06%
+103.4%
FATE  FATE THERAPEUTICS INC$1,230,000
+37.0%
70,0000.0%0.06%
+32.6%
FPRX  FIVE PRIME THERAPEUTICS INC$1,206,000
+44.1%
90,0000.0%0.06%
+40.0%
VIPS  VIPSHOP HLDGS LTDsponsored ads a$1,008,000
+46.9%
125,6150.0%0.05%
+42.4%
ELGXQ NewENDOLOGIX INC$859,000130,000
+100.0%
0.04%
FITB BuyFIFTH THIRD BANCORP$732,000
+17.1%
29,041
+9.3%
0.03%
+13.3%
YNDX SellYANDEX N V$606,000
-59.4%
17,643
-67.6%
0.03%
-61.1%
YY  YY INCsponsored ads a$547,000
+40.6%
6,5100.0%0.02%
+31.6%
LOMA  LOMA NEGRA CORPsponsored ads$545,000
-1.8%
49,8150.0%0.02%
-7.4%
CIB SellBANCOLOMBIA S Aspon adr pref$459,000
-27.7%
8,993
-46.0%
0.02%
-30.0%
FTSV NewFORTY SEVEN INC$355,00021,957
+100.0%
0.02%
SOGO  SOGOU INCadr repstg a$265,000
+13.2%
44,5760.0%0.01%
+9.1%
SURF ExitSURFACE ONCOLOGY INC$0-160,078
-100.0%
-0.03%
ZTO ExitZTO EXPRESS CAYMAN INCsponsored adr$0-43,093
-100.0%
-0.03%
ELGX ExitENDOLOGIX INC$0-1,135,000
-100.0%
-0.04%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KINROSS GOLD CORP42Q3 20235.5%
BP PLC42Q3 20236.3%
COMCAST CORP NEW42Q3 20233.0%
PUBLIC SVC ENTERPRISE GRP IN42Q3 20232.7%
CISCO SYS INC42Q3 20232.4%
ORACLE CORP40Q1 20232.1%
VODAFONE GROUP PLC NEW39Q3 20237.5%
INTERCONTINENTAL EXCHANGE INC.37Q3 20234.5%
PEPSICO INC37Q2 20223.0%
EOG RES INC36Q3 20231.5%

View ALTRINSIC GLOBAL ADVISORS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ALTRINSIC GLOBAL ADVISORS LLC Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Diversicare Healthcare Services, Inc.Sold outFebruary 10, 202200.0%
AAC Holdings, Inc.Sold outFebruary 12, 202100.0%
trivago N.V.Sold outFebruary 13, 201900.0%
TearLab CorpSold outFebruary 14, 201800.0%
FOSTER WHEELER AGFebruary 13, 20141,488,2361.5%
COOPER COMPANIES INCFebruary 08, 201071,5000.1%
ADVOCAT INCJanuary 14, 2010443,9528.0%

View ALTRINSIC GLOBAL ADVISORS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
SC 13G/A2022-02-10

View ALTRINSIC GLOBAL ADVISORS LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2166725000.0 != 2166729000.0)

Export ALTRINSIC GLOBAL ADVISORS LLC's holdings